TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents
Clinical trial NCT00665847 · COMPLETED
Trial details
- NCT number
- NCT00665847
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2011-05-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.